Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Total Non-Current Liabilities (2019 - 2025)

Bioadaptives' Total Non-Current Liabilities history spans 7 years, with the latest figure at $622164.0 for Q3 2025.

  • For Q3 2025, Total Non-Current Liabilities changed N/A year-over-year to $622164.0; the TTM value through Sep 2025 reached $622164.0, changed N/A, while the annual FY2024 figure was $672554.0, 12.97% down from the prior year.
  • Total Non-Current Liabilities for Q3 2025 was $622164.0 at Bioadaptives, up from $547177.0 in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.3 million in Q3 2021 and bottomed at $502577.0 in Q1 2021.
  • The 5-year median for Total Non-Current Liabilities is $684582.0 (2021), against an average of $720327.5.
  • The largest annual shift saw Total Non-Current Liabilities soared 137.88% in 2021 before it dropped 12.97% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $684582.0 in 2021, then rose by 17.15% to $801959.0 in 2022, then fell by 3.64% to $772757.0 in 2023, then decreased by 12.97% to $672554.0 in 2024, then dropped by 7.49% to $622164.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Total Non-Current Liabilities are $622164.0 (Q3 2025), $547177.0 (Q2 2025), and $689912.0 (Q1 2025).